The global biocompatible 3D printing materials market was valued at USD 394.7 million in 2018 and is expected to reach USD 1,012.2 million in 2026, growing at a CAGR of 13.0% during the forecast period.
Biocompatible 3D Printing Materials Market Segmentation |
|
| By Type | 1. Polymer |
| 2. Metal | |
| 3. Others | |
| By Form | 1. Powder |
| 2. Liquid | |
| 3. Others | |
| By Application | 1. Implants & Prosthesis |
| 2. Prototyping & Surgical Guides | |
| 3. Tissue Engineering | |
| 4. Hearing Aid | |
| 5. Others | |
| By Region | 1. North America (US and Canada) |
| 2. Europe (UK, Germany, France and Rest of Europe) | |
| 3. Asia Pacific (China, Japan, India and Rest of Asia Pacific) | |
| 4. Latin America (Brazil, Mexico and Rest of Latin America) | |
| 5. Middle East & Africa (GCC and Rest of Middle East & Africa) | |
The biocompatible 3D printing materials are used in various medical applications including prototyping & surgical guides, implants & prosthesis, hearing aid, tissue engineering, and others. The 3D printing technologies are developed to enhance the unique design freedom. The biocompatible 3D printing materials are becoming popular due to its reduced lead time and excessive costs owing to tool-less processes.
Growing pharmaceutical industries, growing demand for biocompatible 3D printing materials, particularly in the implants & prosthesis application, and mass customization of biocompatible 3d printing materials and reduced production time and specifically tailored products are the main drivers for the market growth of the global biocompatible 3D printing materials market over the forecast period. Moreover, the increase in research and development in new medicals applications across the globe is expected to enhance the market size. This also expected to open investment opportunities in the global market for the manufacturers in the coming years. The rise in adoption of 3d printing technology in bioprinting organs and increase in government spending in 3D printing offers huge growth opportunities for biocompatible 3D printing materials market in the coming years.
However, high cost of materials and complexity of design are expected to hamper the growth of the global biocompatible 3D printing materials market during the forecast period. Moreover, producing low-cost 3d printing materials and developing FDA compliant 3d printing biomaterials are the prime challenges in the global biocompatible 3D printing materials market throughout the forecast period.
The polymer segment expected to dominate the market throughout the forecast period
Based on type, the global biocompatible 3D printing materials market has been segmented into polymer, metal, and others. The polymer segment accounted for approximately 24% of the share in the global biocompatible 3D printing materials market in 2018. The major factors that are driving the growth of this segment are the rising demand of polymer due to cheaper, easily moldable, and degradable and used in various applications such as tissue engineering, hearing aids, prototyping, and surgical guides.
Based on form, the powder segment is expected to dominate during the forecast period
Based on form, the market has been segmented into powder, liquid, and others. The powder segment accounts of the largest share in the market and held for more than 50% of the total market in 2018. The major factors that are driving the growth of this segment are the compatibility with several 3D printers and rising demand from medical applications such as bio fabrication, implants & prosthesis, and surgical instruments.
Based on application, the tissue engineering segment is expected to dominant the market during the forecast period
Based on application, the market has been segmented into implants & prosthesis, prototyping & surgical guides, tissue engineering, hearing aid, and others. The tissue engineering application segment accounts of the largest share in the global biocompatible 3D printing materials market by application. The major factors that are driving the growth of this segment are the growing cases of tissue or organ failure due to age, diseases, accidents, and congenital disabilities and growth in research and development made on bio fabrication of body parts and organ printing.
The manufacturers Evonik Industries AG, 3D Systems, Inc., and Stratasys Ltd are the mainly investing in the development of tissue engineering for the biocompatible 3D printing materials, which expected the lead the market in the coming years.
North America to dominate the biocompatible 3D printing materials market throughout the forecast period
North America accounted for nearly 43% share of the global biocompatible 3D printing materials market in 2018 and is expected to dominate the market throughout the forecast period. Increasing government investments in 3D printing, well-established research, and development centers and rise in a number of manufacturers and a strong economy to support research funding are the major driving factor for the region in the global market.
Asia-Pacific is expected to hold the highest CAGR in the global market during the forecast period. The manufacturers are investing in the development of biocompatible 3D printing materials, growing demand for biocompatible 3D printing materials in developing countries and rising awareness about healthcare are expected to enhance the market growth in the global biocompatible 3D printing materials market during the forecast.
Company Profiles and Competitive Intelligence:
The major players operating in the global biocompatible 3D printing materials market are Evonik Industries AG (Germany), 3D Systems, Inc. (US), Stratasys Ltd. (US), Concept Laser, GmBH (Germany), EOS GmBH Electro Optical Systems (Germany), Renishaw PLC. (UK), Formlabs Inc. (US), EnvisionTEC, Inc. (Germany), 3D Composites (US), and Aspect Biosystems Ltd. (Canada) among others.
Ask for free product review call with the author
Share your specific research requirements for a customized report
Request for due diligence and consumer centric studies
Request for study updates, segment specific and country level reports
TABLE OF CONTENT
Chapter 1 Executive Summary
1.1. Market Summary
1.1.1. Global Biocompatible 3D Printing Materials Market, 2016-2026, (USD Million)
1.2. Market Snapshot: Global Biocompatible 3D Printing Materials Market
1.3. Market Dynamics
1.4. Global Biocompatible 3D Printing Materials Market, by Segment, 2018
1.4.1. Global Biocompatible 3D Printing Materials Market, by Type, 2018, (USD Million)
1.4.2. Global Biocompatible 3D Printing Materials Market, by Form, 2018, (USD Million)
1.4.3. Global Biocompatible 3D Printing Materials Market, by Application, 2018, (USD Million)
1.4.4. Global Biocompatible 3D Printing Materials Market, by Region, 2018 (USD Million)
1.5. Premium Insights
1.5.1. Biocompatible 3D Printing Materials Market In Developed Vs. Developing Economies, 2018 vs 2026
1.5.2. Global Biocompatible 3D Printing Materials Market: Regional Life Cycle Analysis
Chapter 2 Market Dynamics
2.1. Market Overview
2.2. Market Drivers
2.2.1. Rising Demand of biocompatible 3D printing materials in new medical applications
2.2.2. Reduced production time and specifically tailored products
2.3. Market Restraints
2.3.1. High material costs
2.4. Market Opportunities
2.4.1. Increasing Government Investments in 3D Printing
2.5. Industry Value Chain Analysis
2.6. Pricing Analysis
2.7. Porter’s Five Forces Analysis
Chapter 3 Global Biocompatible 3D Printing Materials Market, by Type
3.1. Market Overview, by Type
3.1.1. Global Biocompatible 3D Printing Materials Market, by Type, 2016-2026 (USD Million)
3.1.2. Incremental Opportunity, by Type, 2018
3.2. Polymer
3.2.1. Global Biocompatible 3D Printing Materials Market, by Polymer, 2016-2026, (USD Million)
3.3. Metal
3.3.1. Global Biocompatible 3D Printing Materials Market, by Metal, 2016-2026, (USD Million)
3.4. Others
3.4.1. Global Biocompatible 3D Printing Materials Market, by Others, 2016-2026, (USD Million)
Chapter 4 Global Biocompatible 3D Printing Materials Market, by Form
4.1. Market Overview, by Form
4.1.1. Global Biocompatible 3D Printing Materials Market, by Form, 2016-2026 (USD Million)
4.1.2. Incremental Opportunity, by Form, 2018
4.2. Powder
4.2.1. Global Biocompatible 3D Printing Materials Market, by Powder, 2016-2026, (USD Million)
4.3. Liquid
4.3.1. Global Biocompatible 3D Printing Materials Market, by Liquid, 2016-2026, (USD Million)
4.4. Others
4.4.1. Global Biocompatible 3D Printing Materials Market, by Others, 2016-2026, (USD Million)
Chapter 5 Global Biocompatible 3D Printing Materials Market, by Application
5.1. Market Overview, by Application
5.1.1. Global Biocompatible 3D Printing Materials Market, by Application, 2016-2026 (USD Million)
5.1.2. Incremental Opportunity, by Application, 2018
5.2. Implants & Prosthesis
5.2.1. Global Biocompatible 3D Printing Materials Market, by Implants & Prosthesis, 2016-2026, (USD Million)
5.3. Prototyping & Surgical Guides
5.3.1. Global Biocompatible 3D Printing Materials Market, by Prototyping & Surgical Guides, 2016-2026, (USD Million)
5.4. Tissue Engineering
5.4.1. Global Biocompatible 3D Printing Materials Market, by Tissue Engineering, 2016-2026, (USD Million)
5.5. Hearing Aid
5.5.1. Global Biocompatible 3D Printing Materials Market, by Hearing Aid, 2016-2026, (USD Million)
5.6. Others
5.6.1. Global Biocompatible 3D Printing Materials Market, by Others, 2016-2026, (USD Million)
Chapter 6 Global Biocompatible 3D Printing Materials Market, by Region
6.1. Market Overview, by Region
6.1.1. Global Biocompatible 3D Printing Materials Market, by Region, 2016-2026, (USD Million)
6.2. Attractive Investment Opportunity, by Region, 2018
6.3. North America Biocompatible 3D Printing Materials Market
6.3.1. North America Biocompatible 3D Printing Materials Market, by Type, 2016-2026 (USD Million)
6.3.2. United States Biocompatible 3D Printing Materials Market, 2016-2026 (USD Million)
6.3.3. Canada Biocompatible 3D Printing Materials Market, 2016-2026 (USD Million)
6.4. Europe Biocompatible 3D Printing Materials Market
6.4.1. Europe Biocompatible 3D Printing Materials Market, by Type, 2016-2026 (USD Million)
6.4.2. United Kingdom Biocompatible 3D Printing Materials Market, 2016-2026 (USD Million)
6.4.3. Germany Biocompatible 3D Printing Materials Market, 2016-2026 (USD Million)
6.4.4. France Biocompatible 3D Printing Materials Market, 2016-2026 (USD Million)
6.4.5. Rest of Europe Biocompatible 3D Printing Materials Market, 2016-2026 (USD Million)
6.5. Asia Pacific Biocompatible 3D Printing Materials Market
6.5.1. Asia Pacific Biocompatible 3D Printing Materials Market, by Type, 2016-2026 (USD Million)
6.5.2. China Biocompatible 3D Printing Materials Market, 2016-2026 (USD Million)
6.5.3. Japan Biocompatible 3D Printing Materials Market, 2016-2026 (USD Million)
6.5.4. India Biocompatible 3D Printing Materials Market, 2016-2026 (USD Million)
6.5.5. Rest of Asia Pacific Biocompatible 3D Printing Materials Market, 2016-2026 (USD Million)
6.6. Latin America Biocompatible 3D Printing Materials Market
6.6.1. Latin America Biocompatible 3D Printing Materials Market, by Type, 2016-2026 (USD Million)
6.6.2. Brazil Biocompatible 3D Printing Materials Market, 2016-2026 (USD Million)
6.6.3. Mexico Biocompatible 3D Printing Materials Market, 2016-2026 (USD Million)
6.6.4. Rest of Latin America Biocompatible 3D Printing Materials Market, 2016-2026 (USD Million)
6.7. Middle East & Africa Biocompatible 3D Printing Materials Market
6.7.1. Middle East & Africa Biocompatible 3D Printing Materials Market, by Type, 2016-2026 (USD Million)
6.7.2. GCC Biocompatible 3D Printing Materials Market, 2016-2026 (USD Million)
6.7.3. Rest of Middle East & Africa Biocompatible 3D Printing Materials Market, 2016-2026 (USD Million)
Chapter 7 Competitive Intelligence
7.1. Top 5 Players Comparison
7.2. Market Positioning of Key Players, 2018
7.3. Market Players Mapping
7.3.1. By Type
7.3.2. By Form
7.3.3. By Application
7.3.4. By Region
7.4. Strategies Adopted by Key Market Players
7.5. Recent Developments in the Market
7.5.1. Mergers & Acquisitions, Partnership, New Type Developments
Chapter 8 Company Profiles
8.1. Evonik Industries AG
8.1.1. Evonik Industries AG Overview
8.1.2. Evonik Industries AG Types Portfolio
8.1.3. Evonik Industries AG Financial Overview
8.1.4. Evonik Industries AG News/Recent Developments
8.2. 3D Systems, Inc.
8.2.1. 3D Systems, Inc. Overview
8.2.2. 3D Systems, Inc. Types Portfolio
8.2.3. 3D Systems, Inc. Financial Overview
8.2.4. 3D Systems, Inc. News/Recent Developments
8.3. Stratasys Ltd
8.3.1. Stratasys Ltd Overview
8.3.2. Stratasys Ltd Types Portfolio
8.3.3. Stratasys Ltd Financial Overview
8.3.4. Stratasys Ltd News/Recent Developments
8.4. Concept Laser GmbH
8.4.1. Concept Laser GmbH Overview
8.4.2. Concept Laser GmbH Types Portfolio
8.4.3. Concept Laser GmbH Financial Overview
8.4.4. Concept Laser GmbH News/Recent Developments
8.5. Eos GmbH Electro Optical Systems
8.5.1. Eos GmbH Electro Optical Systems Overview
8.5.2. Eos GmbH Electro Optical Systems Types Portfolio
8.5.3. Eos GmbH Electro Optical Systems Financial Overview
8.5.4. Eos GmbH Electro Optical Systems News/Recent Developments
8.6. Renishaw Plc
8.6.1. Renishaw Plc Overview
8.6.2. Renishaw Plc Types Portfolio
8.6.3. Renishaw Plc Financial Overview
8.6.4. Renishaw Plc News/Recent Developments
8.7. Formlabs, Inc.
8.7.1. Formlabs, Inc. Overview
8.7.2. Formlabs, Inc. Types Portfolio
8.7.3. Formlabs, Inc. Financial Overview
8.7.4. Formlabs, Inc. News/Recent Developments
8.8. Envisiontec, Inc.
8.8.1. Envisiontec, Inc. Overview
8.8.2. Envisiontec, Inc. Types Portfolio
8.8.3. Envisiontec, Inc. Financial Overview
8.8.4. Envisiontec, Inc. News/Recent Developments
8.9. 3D Composites
8.9.1. 3D Composites Overview
8.9.2. 3D Composites Types Portfolio
8.9.3. 3D Composites Financial Overview
8.9.4. 3D Composites News/Recent Developments
8.10. Aspect Biosystems Ltd.
8.10.1. Aspect Biosystems Ltd. Overview
8.10.2. Aspect Biosystems Ltd. Types Portfolio
8.10.3. Aspect Biosystems Ltd. Financial Overview
8.10.4. Aspect Biosystems Ltd. News/Recent Developments
Chapter 9 Preface
9.1. Data Triangulation
9.2. Research Methodology
9.2.1. Phase I – Secondary Research
9.2.2. Phase II – Primary Research
9.2.3. Phase III – Expert Panel Review
9.2.4. Approach Adopted
9.2.4.1. Top-Down Approach
9.2.4.2. Bottom-Up Approach
9.2.5. Supply- Demand side
9.2.6. Breakup of the Primary Profiles
Log in / Register
